Through immunohistochemistry (IHC) staining, measurement of ZBTB16 expression levels in the TCGA database, and quantitative polymerase chain reaction (qPCR) confirmation, it was found that ZBTB16 is downregulated in lung cancer samples, indicating its potential role as a diagnostic biomarker. The gene discussed is ZBTB16; the disease is lung carcinoma.